This isn't a telehealth subscription
Skonieczna-ydecka K, oniewski I, Misera A, Stachowska E, Maciejewska D, Marlicz W, et al
SUSTAIN program: Multiple trials in type 2 diabetes
What it claims 'Accelerates tissue repair', 'heals tendons and gut lining', 'reverses joint wear' mostly attached to BPC-157 and TB-500 'Builds collagen from the inside', 'firmer skin in 8 weeks', 'stronger hair and nails' collagen peptides and GHK-Cu 'Master antioxidant', 'detoxifies at the cellular level' oral and liposomal glutathione 'Growth-hormone optimisation without the risks' CJC-1295/Ipamorelin and other secretagogue stacks 'Research grade', 'pharmaceutical purity', '99%+ HPLC verified' the standard reassurance on grey-market sites What the label is not telling you BPC-157 is not an approved drug anywhere, and the human evidence is close to zero